Abiomed Impella RP Manual Del Usuario página 6

4
INDICATIONS
The Impella RP System (percutaneous pump for right ventricular support) is intended for clinical
®
use in cardiology, in cardiac surgery, and intensive care unit for up to 14 days for the following
indications, as well as others:
• Acute or transient reduction of the right ventricular function (eg, postcardiotomy low output
syndrome)
• Cardiogenic shock as a consequence of a posterior myocardial infarction with right
ventricular heart failure
• Right heart support during coronary beating heart bypass surgery, especially for patients
with a reduced preoperative cardiac output or for patients having a high risk of developing
a postoperative low output syndrome for other reasons
• Right ventricular heart failure after implantation of a left ventricular assist device
• Therapy unresponsive arrhythmias with a reduction of right ventricular output
• Heart failure and/or cardiogenic shock as a consequence of refractory ventricular
arrhythmias, as well as a consequence of sustained supraventricular arrhythmias, causing
haemodynamic compromise.
CONTRAINDICATIONS
• Arteriosclerosis, in particular calcification or other disorders of the pulmonary artery wall
• Mechanical valves, severe valvular stenosis or valvular regurgitation of the tricuspid valve or
pulmonary valve
• Mural thrombus of the right atrium or vena cava
• Anatomic conditions precluding insertion of the pump
• Other illnesses or therapy requirements precluding use of the pump
• Presence of a vena caval filter or caval interruption device, unless there is clear access from
the femoral vein to the right atrium that is large enough to accommodate a 22 Fr catheter
User Manual